Integrated Investment Consultants LLC Has $448,000 Stock Position in Danaher Co. (NYSE:DHR)

Integrated Investment Consultants LLC decreased its holdings in Danaher Co. (NYSE:DHR) by 8.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,611 shares of the conglomerate’s stock after selling 142 shares during the quarter. Integrated Investment Consultants LLC’s holdings in Danaher were worth $448,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. nVerses Capital LLC bought a new position in shares of Danaher during the second quarter worth about $25,000. CarsonAllaria Wealth Management Ltd. bought a new position in Danaher during the 2nd quarter worth approximately $25,000. MidAtlantic Capital Management Inc. acquired a new position in shares of Danaher in the 3rd quarter worth approximately $40,000. Darwin Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter valued at $55,000. Finally, MFA Wealth Advisors LLC acquired a new stake in shares of Danaher during the second quarter worth $51,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

DHR has been the topic of several recent analyst reports. Barclays dropped their target price on shares of Danaher from $285.00 to $275.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 23rd. Stifel Nicolaus boosted their price objective on Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research note on Wednesday, October 23rd. Royal Bank of Canada cut their target price on Danaher from $333.00 to $311.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 23rd. TD Cowen lifted their target price on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Finally, Wolfe Research upgraded Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 price target on the stock in a report on Thursday, October 31st. Six investment analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $287.16.

Insider Transactions at Danaher

In other news, SVP Georgeann Couchara sold 952 shares of the business’s stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $268.37, for a total value of $255,488.24. Following the transaction, the senior vice president now owns 4,212 shares in the company, valued at $1,130,374.44. The trade was a 18.44 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of NYSE DHR opened at $234.76 on Friday. The stock has a market cap of $169.56 billion, a price-to-earnings ratio of 44.80, a PEG ratio of 4.25 and a beta of 0.85. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. Danaher Co. has a fifty-two week low of $215.68 and a fifty-two week high of $281.70. The firm’s 50-day simple moving average is $258.92 and its 200 day simple moving average is $259.96.

Danaher (NYSE:DHR) last posted its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. During the same quarter last year, the company earned $2.02 earnings per share. The company’s revenue for the quarter was up 3.1% on a year-over-year basis. As a group, research analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current fiscal year.

Danaher Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 25th. Shareholders of record on Friday, September 27th were issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.46%. The ex-dividend date was Friday, September 27th. Danaher’s dividend payout ratio is 20.61%.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.